• Boston PEGS Conference

    AbSci will join worldwide leaders in the proteins and antibodies sector this May at PEGS to unveil the soluble, high-titer expression of full-length antibodies in E. coli

  • Revolutionizing Protein Expression

    Bringing down the costs of biologic drugs is an integral step in making tomorrows therapeutics accessible today.

  • Sustainable Energy Production

    Converting waste products instead of food stocks is the key to sustainable bioethanol production.

  Welcome to AbSci, LLC.

A leading provider of Streamlined Soluble Protein Expression for the pharmaceutical industry.

AbSci's SoluPro is a proprietary, bioengineered expression platform that allows for easily optimizable and scalable production of complex proteins, including monoclonal antibodies.  The core technology allows proteins to be produced at a fraction of their current cost, while maintaining all of their performance characteristics.

These benefits are realized at both the R&D stage, where this all-in-one solution will enable quicker access to these valuable proteins for screening purpsoses, as well as in biopharmaceutical manufacturing. This breakthrough technology eliminates inclusion body formation, and aims to replace mammalian systems as the primary platform for expression of these valuable proteins. Once fully utilized within the industry, SoluPro will help make next generation biologic drugs affordable and accessible for the millions of patients who need them today.

Read more


AbSci's expression platform is robust and highly flexible, and allows for production of therapeutic proteins and antibodies at a fraction of current cost.

learn more


AbSci is committed to sustainable energy production. Our expression platform alleviates the major bottleneck of non-food based biofuels by efficiently producing lignin-degrading enzymes.

learn more

© AbSci, LLC 2013. All rights Reserverd. Site by Skyhound Internet